Abstract
This study of frontotemporal dementia (FTD) was carried out to determine whether MR spectroscopy can provide an in vivo marker for the neuronal loss and gliosis that occur in this condition. We compared spectra in frontal and temporal regions known to be affected early in the course of the disease with spectra in the parietal lobe that is spared until late stages of FTD. We were interested in the relative concentrations of two compounds, NAA (a marker of neuronal integrity) and mI (a marker of gliosis), expressed as ratios to creatine (a relatively stable brain constituent). MR spectroscopy was performed on the temporal, parietal, and anterior cingulate cortices of five patients with the established semantic dementia form of FTD, two patients with the frontal form of FTD and 13 age matched controls. Structural MRI and neuropsychometry were also performed. Patients with FTD had reduced NAA/Cr in frontal and temporal, but not parietal lobes. The two patients with the frontal form of FTD had increased mI/Cr in their cingulate cortices. These data show for the first time that MR spectroscopy can reveal regionally selective abnormalities in patients with FTD. This opens up the possibility of using MR spectroscopy as a clinical tool to identify earlier presentations of the condition.
Similar content being viewed by others
References
Delis DC, Kramer JH, Kaplan E (2001) Delis-Kaplan Executive Function System Examiner’s Manual. The Psychological Association: A Harcourt Assessment Company, San Antonio
Ernst T, Chang L, Melchor R, Mehringer CM (1997) Frontotemporal dementia and early Alzheimer’s disease: differentiation with frontal lobe H-1 MR spectroscopy. Radiology 203:829–836
Ernst T, Kreis R, Ross BD (1993) Absolute quantitation of water and metabolites in the human brain. J Magn Reson B 102:1–8
Firbank M, Harrison RM, O’Brien JT (2002) A comprehensive review of proton magnetic resonance spectroscopy studies in dementia and Parkinson’s disease. Dementia and Geriatric Cogn Disord 14:64–76
Gadian D (1995) NMR and its applications to living systems. Oxford Science Publications (OUP) 2nd edition
Hodges JR, Miller B (2001) The Classification, Genetics and Neuropathology of Frontotemporal dementia. Introduction to the Special Topic Papers: Part I Neurocase 7:31–35
Jackson MLJ (1996) The new neuropathology of degenerative frontotemporal dementias. Acta Neuropathol (Berl) 91:127–134
Kantarci KMPRC, Boeve BF, Knopman DS, Tang-Wai DF, O’Brien PC, Weigand SD, Edland SD, Smith GE, Ivnik RJ, Ferman TJ, Tangalos EG, Jack CR Jr (2004) 1H MR spectroscopy in common dementias. Neurology 63
McKenna PWE (1980) Testing for Nominal Dysphasia. J Neurol Neurosurg Psychiatry 43:781–788
McKhann GM, Albert MS, Grossman M, Miller B, Dickinson D, Trojanowski J (2001) Clinical and Pathological Diagnosis of Frontotemporal Dementia. Arch Neurol 58:1803–1809
Miller B (1991) A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed 4:47–52
Mummery CJ, Patterson K, Price SJ, Ashburner J, Freckowiak RSJ, Hodges JR (2000) A voxel-based morphometry study of semantic dementia: Relationship between temporal lobe atrophy and semantic memory. Ann Neurol 47:36–45
Naressi A, Couturier C, Castang I, de Beer R, Graveron-Demilly D (2001) Java-based graphical user interface for MRUI, a software package for quantitation of in vivo/medical magnetic resonance spectroscopy signals. Comput Biol Med 31:269–286
Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF (1998) Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology 51:15446–11554
Rosen H, Gorno-Tempini ML, Goldman WP, Perry RJ, Schuff N, Weiner M, Feiwell R, Kramer JH, Miller BL (2002) Patterns of brain atrophy in frontotemporal dementia and semantic dementia. Neurology 58:198–208
Rudkin TM, Douglas LA (1999) Proton Magnetic Resonance Spectroscopy for the Diagnosis and Management of cerebral disorders. Arch Neurol 56:919–926
Schofield E, Kersaitis C, Shepherd CE, Kril JJ, Halliday G (2003) Severity of gliosis in Pick’s Disease and frontotemporal lobar degeneration: tau-positive glia differentiate these disorders. Brain 126:827–840
Taniguchi S-MAM, Pickering-Brown SM, Umeda Y, Iwatsubo T, Hasegawa M, Mann DMA (2004) The neuropathology of frontotemporal lobar degeneration with respect to the cytological and biochemical characteristics of tau protein. Neuropathol Appl Neurobiol 30:1–18
Valenzuela MJ, Perminder Sachdev (2001) Magnetic resonance spectroscopy in AD. Neurology 56:592–598
Wechsler D (1991) Wechsler Adult Intelligence Scale-III. New York Psychological Corporation
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Coulthard, E., Firbank, M., English, P. et al. Proton magnetic resonance spectroscopy in frontotemporal dementia. J Neurol 253, 861–868 (2006). https://doi.org/10.1007/s00415-006-0045-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-006-0045-y